On May 16 announced Glaxo-Smith-Kline Pharmaceuticals, maker of Imitrex, the release of a new drug for the treatment of migraine. The new drug was to be called Treximet and according to the creators, would be a huge improvement over Imitrex. As Imitrex, is made in the beginning of a migraine can be taken, but the work faster and easier to relieve the pain of migraine. GSK has a number of years and millions of dollars researching and "Pre-Marketing" spent TreximetLooking forward to FDA approval and product launch.
So what's the problem? But it is really better than Imitrex alone? From a strict treatment point of view, yes, the drug is...